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Introduction
Oral squamous cell carcinoma (OSCC) is one of the most common malignant tumors in the oral and maxillofacial region. It is estimated to be the ninth most common cancer worldwide, and its incidence rate has been showing an increasing trend [1] . Despite advances in medical and surgical treatments, most OSCC patients are diagnosed at an advanced stage and have a poor prognosis, with an overall 5-year survival rate of 50-60% [2] . Classic tumor markers such as serum squamous cell carcinoma antigen, carbohydrate antigen 19-9, and carcinoembryonic antigen are used in the management of patients with OSCC. However, due to insufficient diagnostic sensitivity and specificity, they have limited utility in the early detection of this disease [3] . Therefore, new biomarkers with high sensitivity and specificity should be explored for the early detection of OSCC.
Circular RNAs (circRNAs) are a class of endogenous RNAs that are characterized by covalently closed loop structures without a 5′ cap or a 3′ poly(A) tail [4] . There is increasing evidence that circRNAs play important roles in the regulation of gene expression at the posttranscriptional level [5] [6] [7] . Accordingly, it has been demonstrated that many circRNAs serve as competing endogenous RNAs to bind with microRNAs (miRNAs) and inhibit the activity and function of the targeted miRNAs [8, 9] . With the increasing number of studies on circRNAs, circRNAs have been shown to be involved in the development of several types of diseases, including cancer [10] , cardiovascular disease [11] , and neurological disorders [12] . Unlike linear RNA, circRNAs have a special circular covalently bonded structure, which facilitates their higher stability and resistance to RNA exonucleases [13] . The expression of circRNAs in human blood and gastric fluid also increases their potential as disease biomarkers [14] . For example, Zhao et al [15] . discovered that peripheral blood hsa_circ_0124644 can be used as a diagnostic biomarker of coronary artery disease and Yin et al [16] . reported that plasma hsa_circ_0001785 can serve as a diagnostic biomarker for breast cancer detection. Saliva contains an array of analytes (protein, mRNA, and DNA) that can be used as biomarkers for translation and clinical applications [17] . Using bioinformatics analysis, Bahn et al [18] . identified many circRNAs in human saliva and suggested salivary circRNAs are potential non-invasive biomarkers for the diagnosis of human diseases.
In this study, we used microarray analysis to compare the expression profile of circRNAs in the saliva of OSCC patients and matched control subjects and then confirmed our findings in larger independent cohorts. Our results indicate the potential of salivary hsa_circ_0001874 and hsa_circ_0001971 as biomarkers for the diagnosis of OSCC.
Materials and Methods

Patient variables
A total of 93 consecutive patients with OSCC were recruited from the Affiliated Stomatological Hospital of Nanchang University between January 2016 and May 2017. All were newly diagnosed and previously untreated (e.g., no surgery, chemotherapy, or radiotherapy). Their clinicopathological data included age, sex, location, size, and grade of tumor, distant metastasis, and TNM stage. In addition, 70 subjects who were clinically and pathologically diagnosed with oral leukoplakia (OLK) were recruited for this study. To serve as controls, 85 individuals who sought a routine health check-up in the same period and did not have any oral diseases or other cancerous diseases were recruited. Among the participants, 3 OSCC patients and 3 age-and sex-matched healthy controls were recruited for microarray analysis. Other samples were used Collection of saliva samples and extraction of total RNA Before saliva collection, each individual fasted, was prohibited from drinking and smoking, and had not brushed their teeth, rinsed, or flossed for at least 2 h. Each saliva sample was centrifuged at 4°C at 3000 × g for 15 min, after which the supernatant was transferred to a 1.5-mL EP tube. The supernatant was centrifuged at 4°C at 12000 × g for 10 min and the supernatant was collected. After separation, saliva samples were stored at -80°C until total RNA extraction. Total RNA was isolated using the miRNeasy Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer's protocol. The RNA concentration was measured using the NanoDrop™1000 spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA).
Microarray analysis of circRNA expression
The Human CircRNA Array is manufactured by Arraystar Inc. (Rockville, MD, USA). For microarray analysis, total RNA was digested with RNase R (Epicentre Inc., Madison, WI, USA) to remove linear RNAs and enrich circRNAs. The enriched circRNAs were amplified and transcribed into fluorescent circRNAs utilizing a random priming method (Arraystar Super RNA Labeling Kit; Arraystar Inc.). The labeled circRNAs were hybridized to the Arraystar Human circRNA Microarray version (Arraystar Inc.). After washing the slides, the arrays were scanned with the Agilent Scanner G2505C (Agilent Technologies, Santa Clara, CA, USA). Agilent Feature Extraction software (version 11.0.1.1) was used to analyze the acquired array images. Quantile normalization and subsequent data processing were performed using the R software package (R version 3.1.2). The microarray was performed by KangChen Bio-tech (Shanghai, China). Student's t-test was performed to determine statistical differences. A false discovery rate (FDR) less than 0.05 was applied to determine the threshold P value. Differentially expressed circRNAs with statistical significance (fold-change ≥1.5 and P<0.05) between groups were identified using a fold-change cut-off.
Quantitative real-time PCR analysis
Total RNA (800 ng) from each saliva sample was reverse-transcribed into cDNA with a random primer using the PrimeScript™ RT Reagent Kit (Takara Bio Inc., Tokyo, Japan) according to the manufacturer's instructions. To confirm the specificity of PCR amplification, total RNA was pretreated with DNase I to remove trace genomic DNA, and with RNase R (Epicentre Inc.) to remove all linear RNAs before reverse transcription. Then, quantitative real-time (qRT)-PCR was conducted on the ABI 7500 Real-Time PCR System (Applied Biosystems; Thermo Fisher Scientific) using SYBR ® Premix Ex Taq™ II (Takara) in 20 mL reactions containing 1×SYBR Green PCR Master Mix, 0.4 mM of each forward and reverse primer, and 1 mL cDNA template. The PCR assay was conducted at an initial denaturation step at 95°C for 5 min, followed by 40 cycles at 95°C for 15 s and at 60°C for 1 min. The melting curve was analyzed to confirm the specificity of amplification and lack of primer dimers. The primers used in qRT-PCR are shown in Table 1 . All qRT-PCR experiments were performed in triplicate. qRT-PCR data were analyzed by the ΔCt method and normalized to the internal control (β-actin). Larger ΔCt values indicated lower expression. The specificity of the qRT-PCR product of circRNA was determined by electrophoresis, melting curve analysis, and sequencing. Sanger sequencing of the qRT-PCR products confirmed the back-splice junction sequence of circRNA, which was consistent with that shown in the database (http://www.circbase.org/cgi-bin/simplesearch.cgi). 
Statistical analysis
Statistical analysis and graphic presentation were conducted using SPSS version 17.0 (SPSS Inc., Chicago, IL, USA) and GraphPad Prism version 5.0 (GraphPad Software, San Diego, CA, USA). The statistical significance of microarray data was analyzed in terms of fold change using Student's t-test, and FDR was calculated to correct the P-value. Numerical data are shown as the mean ± standard error of the mean (SEM). The Mann-Whitney U test or Student's t-test was used for statistical analysis, and the Wilcoxon test was used to compare the paired saliva samples before and 1 month after surgery. Receiver operating characteristic (ROC) curves were constructed, and the area under curve (AUC) was used to assess the sensitivity and specificity of the predictive power of using salivary circRNAs as biomarkers for OSCC. The ROC curve was used to classify the results of discriminant analysis and evaluation. An ROC curve requires a binary variable, but the analysis can be applied to a continuous variable by encoding it into two categorical variables. Here, the decision of a cutoff value is made by varying the value and calculating the sensitivity (sensitivity) and false positive rate (1-Specificity (specificity)), with sensitivity along the vertical axis, to calculate the error as described in Wang et al [19] .. Curves are drawn to connect the points, and the area under the curve is calculated, with larger areas indicating greater error. The AUC is calculated as follows. First, the scores are arranged in order of descending score, and the maximum score corresponds to the sample if the rank is n, the second-highest score corresponds to a rank of n -1, and so on. The ranks of all positive classes are summed, and the average of M and 1 + M is subtracted, where M is the number of positive class samples. This intermediate score is then divided by the product M × N. This is written as the following.
In addition, special attention is required for the case of a tie score. Two samples with the same score must be given the same rank (whether the scores are in the same sample or in different types of samples). The samples thus need equal rank score averaging, which the above formula achieves. The association between the clinical features and salivary circRNA expression was evaluated by the chi-squared test. P values (two-tailed) less than 0.05 were considered statistically significant.
Results
CircRNA expression profiles in saliva from OSCC patients
To identify circRNAs that were differentially expressed in OSCC patients, we performed microarray analysis of circRNAs in the saliva from 3 OSCC patients and 3 age-and sexmatched healthy controls using the Arraystar Human circRNA Microarray. Hierarchical clustering (Fig. 1A ) and scatter plot (Fig. 1B) visualization showed that the expression levels of circRNAs were variable between OSCC patients and healthy controls. Differentially expressed circRNAs with statistical significance between the two groups were identified using volcano plot filtering (Fig. 1C) : 32 circRNAs were differentially expressed (fold-change ≥1.5 and P<0.05), 12 of which were upregulated and 20 of which were downregulated in OSCC patients. The top 20 differentially expressed circRNAs are listed in Table 2 . Among the upregulated circRNAs, there were 10 exonic, 1 intronic, and 1 sense overlapping. Among the downregulated circRNAs, there were 17 exonic, 2 intronic, and 1 sense overlapping. To identify the most clinically applicable biomarker, we chose the 3 circRNAs that showed the highest fold changes from the upregulated circRNAs (hsa_circ_0001874, hsa_circ_0001971, and hsa_circ_0008068) and 3 circRNAs that showed the highest fold changes from the downregulated circRNAs (hsa_circ_0000140, hsa_circ_0002632, and hsa_circ_0008792) for further validation.
Validation of circRNAs expression
To validate the circRNA microarray results, qRT-PCR was performed to analyze the selected circRNAs. The results showed that hsa_circ_0001874, hsa_circ_0001971, and hsa_ circ_0008068 levels were increased, whereas hsa_circ_0000140, hsa_circ_0002632, and hsa_ circ_0008792 levels were decreased in OSCC patients compared with the healthy controls (P<0.001; Fig. 2 ). These results were generally consistent with the microarray data. Sanger sequencing of the qRT-PCR products confirmed the back-splice junction sequence of these six circRNAs which were consistent with that from database (http://circinteractome.nia.nih. gov/) showed (Fig. 3) .
ROC curve analysis of differentially expressed circRNAs
To compare the diagnostic value of these confirmed salivary circRNAs as candidate biomarkers of OSCC, ROC curve analysis was performed on data from the validation set. As shown in Fig. 4 , the AUC was larger than 0.650 for all 6 candidate circRNAs, suggesting their potential diagnostic value. Notably, the AUC of hsa_circ_0001874 reached 0. The sensitivity and specificity of each circRNA were determined based on the cut-off value (Table 3) .
Association between salivary circRNA expression and clinicopathological characteristics of OSCC patients
We also examined the association of these differentially expressed circRNAs with clinicopathological factors in all 90 OSCC patients. OSCC salivary samples were classified into high expression and low expression groups according to the median expression of the salivary circRNAs. As summarized in Table 4 , the expression of salivary hsa_circ_0001874 was closely associated with TNM stage (P=0.006) and tumor grade (P=0.023), and the expression of salivary hsa_circ_0001971 was associated with TNM stage (P=0.019). However, no significant correlations were evident between the expression levels of hsa_circ_0008068, hsa_circ_0000140, hsa_ circ_0002632, and hsa_ circ_0008792l and clinical factors (data not shown). 
Hsa_circ_0001874 and hsa_circ_0001971 expression in patients with OSCC and OLK
We analyzed the expression of salivary hsa_circ_0001874 and hsa_circ_0001971 in 90 OSCC patients and 70 OLK patients. The expression of hsa_circ_0001874 and hsa_ circ_0001971 was significantly increased in OSCC patients compared with OLK patients (all P<0.001; Fig. 5A ). Subsequently, risk scores based on hsa_circ_0001874 and hsa_circ_0001971 were further assessed in OSCC patients and disease controls (OLK; Fig. 5B ): the AUC for risk score based on hsa_circ_0001874 was 0.819 (95% CI: 0.752-0.885; P<0.001), the AUC for risk score based on hsa_circ_0001971 was 0.775 (95% CI: 0.700-0.849; P<0.001), and the AUC for risk score based on both hsa_circ_0001874 and hsa_circ_0001971 was 0.863 (95% CI: 0.808-0.918; P<0.001). The risk score also significantly discriminated between patients with OSCC and all controls (healthy controls and OLK; Fig. 5C ). The AUC for risk score based on hsa_circ_0001874 was 0.843 (95% CI: 0.786-0.899; P<0.001), the AUC for risk score based on hsa_circ_0001971 was 0.812 (95% CI: 0.754-0.871; P<0.001), and the AUC for risk score based on both hsa_circ_0001874 and hsa_circ_0001971 was 0.895 (95% CI: 0.854-0.937; P<0.001).
Correlation of salivary hsa_circ_0001874 and hsa_circ_0001971 expression levels between preoperative and postoperative patients with OSCC
The postoperative saliva samples from 25 patients were collected 1 month after surgery. The expression levels of salivary hsa_circ_0001874 and hsa_circ_0001971 were significantly decreased in postoperative samples compared with preoperative samples (P<0.001) (Fig. 6) . Compared with healthy controls, the mean levels of hsa_circ_0001874 and hsa_circ_0001971 returned to nearly normal after surgical treatment, but with no significant difference between postoperative and healthy controls (P>0.05). 
Discussion
Even though great progress has been made in the early diagnosis, surgical technique, radiation, and chemotherapy of OSCC, the prognosis of patients with this disease is still not ideal due to the lack of non-invasive, rapid, and accurate signatures for OSCC early screening [20] . Salivary screening is currently the best choice as the primary screening test for highrisk cases of OSCC because the collection procedure is noninvasive and low cost [21, 22] . Several studies have demonstrated the feasibility of using salivay miRNAs and long noncoding RNAs (lncRNAs) as potential biomarkers of OSCC [23, 24] . CircRNAs are a naturally occurring type of universal and diverse endogenous non-coding RNA. They are abundant, conserved across species, stably expressed in saliva, blood, and exosomes, and exhibit tissueand developmental stage-specific expression, all of which demonstrate their promise as cancer biomarkers. In addition, circRNAs form a covalently closed continuous loop without 5′ caps and 3′ poly(A) tails, which make them resistant to RNase R activity and more stable than linear lncRNAs. The average half-life of circRNAs in most species is more than 48 h, whereas, on average, the half-life of mRNAs is about 10 h [25] . Studies have shown great potential of circulating circRNAs as powerful and non-invasive biomarkers in a number of diseases [26, 27] . However, the diagnostic performance of saliavry circRNAs in OSCC has not been explored previously.
In this study, we performed a microarray analysis of dysregulated circRNAs by comparing the transcriptome profiles of saliva from patients with OSCC and healthy controls. Compared with healthy controls, we found 12 upregulated and 20 downregulated circRNAs in the saliva of OSCC patients. To identify clinically applicable biomarkers, we detected 6 significantly differentially expressed salivary circRNAs and investigated the association between their expression levels and clinicopathological characteristics of OSCC patients. The validation study demonstrated that salivary levels of hsa_circ_0001874, hsa_circ_0001971, and hsa_ circ_0008068 were remarkably increased, and those of hsa_circ_0000140, hsa_circ_0002632, and hsa_circ_0008792 were remarkably decreased in these patients.
ROC curves were constructed and used to evaluate the discriminatory power of salivary circRNAs for differentiating between OSCC and healthy controls. ROC curve analysis suggested that hsa_circ_0001874 has significant value for OSCC diagnosis, followed by hsa_circ_0001971, hsa_circ_0000140, hsa_circ_0002632, hsa_circ_0008068, and hsa_ circ_0008792. The logistic regression model demonstrated that the combination of hsa_ circ_0001874 and hsa_circ_0001971 have a higher AUC than the individual circRNAs. In addition, we also found that the high expression level of hsa_circ_0001874 was associated with TNM stage and tumor grade, and that the expression level of hsa_circ_0001971 was associated with TNM stage. Risk score based on hsa_circ_0001874 and hsa_circ_0001971 Cellular Physiology and Biochemistry
Cellular Physiology and Biochemistry also demonstrated that they could significantly discriminate patients with OSCC from those with OLK. These results indicate that the altered expression of salivary hsa_circ_0001874 and hsa_circ_0001971 may be related to their involvement in the development and progression of OSCC. Studies have revealed that circRNAs can serve as a miRNA sponge and can interact with miRNA, resulting in an imbalance between miRNA and its target genes, which leads to the initiation and progression of a variety of diseases including cancer [28, 29] . The relationship between miRNAs and OSCC suggest that circRNAs might be involved in the pathogenesis and progression of OSCC. Recently, Chen et al [30] . reported that circRNA_100290 absorbed to miR-29, thereby relieving the inhibition of cell division protein kinase 6 and promoting the proliferation of OSCC. To evaluate the potential functions of hsa_circ_0001874 and hsa_ circ_0001971, the circRNA/miRNA interaction was predicted using Arraystar's homemade miRNA target prediction software based on TargetScan and miRanda. We found that the potential miRNAs targets of hsa_circ_0001874 included miR-661, miR-662, miR-593-5p, miR-107, and miR-103a-3p, and those of hsa_circ_0001971 included miR-152-5p, miR103a-3p, miR-107, miR-505-3p, and miR-9-5p. It is worth noting that miR-107 and miR103a-3p play vital roles in cell division, metabolism, stress response, and angiogenesis [31] . In addition, the dysregulation of miR-107 and miR-103a-3p are involved in the development and progression of multiple tumors [32, 33] . However, due to the limited knowledge of the functions of circRNAs and miRNAs, many of the circRNA/miRNA interactions should be analyzed in future studies.
Several limitations in this study should be acknowledged. First, circRNAs in tissue and plasma were not detected and therefore the circRNA profiles of tissue, plasma, and saliva from the same patient could not be compared simultaneously. Second, the sample size was relatively small and the subjects were limited to a Chinese Han population. Thus, it is necessary to expand the sample size and conduct a multi-center study to validate our findings. Finally, we did not investigate the exact role of circRNAs in OSCC tumorigenesis.
Conclusion
We identified differentially expressed circRNAs in saliva from subjects with OSCC and healthy controls. Furthermore, hsa_circ_0001874 and hsa_circ_0001971 were identified as potential molecular markers for the diagnosis of OSCC. To the best of our knowledge, this is the first study to address salivary circRNA expression profiles in OSCC patients. Further studies are needed on the correlation of the biological function of circRNAs in OSCC, which may be involved in OSCC tumorigenesis and serve as potential novel targets for the early diagnosis, prognostic evaluation, and therapy of patients with OSCC.
